Department of Nuclear Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
Antimicrob Agents Chemother. 2012 Jan;56(1):552-4. doi: 10.1128/AAC.00473-11. Epub 2011 Oct 17.
We investigated the utility of radioimmunotherapy (RIT) in early and established cryptococcal infection in immunocompetent mice. RIT with (213)Bi-18B7 antibody completely eliminated fungus from mouse lungs and brains for early infection, while (188)Re-18B7 significantly reduced CFU in the lungs or both lungs and brains during early and established infection, respectively. The results point to the independence of RIT of the immune status of the host, which is encouraging for translation of this strategy into the clinic.
我们研究了放射免疫疗法(RIT)在免疫功能正常的小鼠中早期和已建立的隐球菌感染中的应用。用(213)Bi-18B7 抗体进行 RIT 治疗可完全清除早期感染小鼠肺部和脑部的真菌,而(188)Re-18B7 分别在早期和已建立的感染时显著降低肺部或肺部和脑部的 CFU。这些结果表明 RIT 独立于宿主的免疫状态,这对于将该策略转化为临床应用是令人鼓舞的。